Argent Capital Management’s Zimmer Biomet ZBH Stock Holding History

Argent Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,551	Closed	-$808K	–	189
2021 Q4	$808K	Sell	6,551 -297,651	-98%	-$39M	0.02%	120
2021 Q3	$43.2M	Sell	304,202 -3,239	-1%	-$476K	1.37%	27
2021 Q2	$48M	Sell	307,441 -5,657	-2%	-$916K	1.5%	25
2021 Q1	$48.7M	Sell	313,098 -8,584	-3%	-$1.33M	1.62%	24
2020 Q4	$48.1M	Sell	321,682 -20,924	-6%	-$2.96M	1.71%	23
2020 Q3	$45.3M	Sell	342,606 -5,562	-2%	-$727K	1.73%	22
2020 Q2	$40.3M	Buy	+348,168	New	+$40.1M	1.69%	22

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Argent Capital Management's ZBH Position: Q1 2022 in Review

Argent Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 6,551 shares — an estimated $808K sold.

Argent Capital Management first reported a position in ZBH in Q2 2020 and held it in 7 quarters. The position peaked at $48.7M in Q1 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

Argent Capital Management reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
Argent Capital Management sold 6,551 Zimmer Biomet shares in Q1 2022, an estimated $808K.
Argent Capital Management first reported a position in Zimmer Biomet in Q2 2020 and held it in 7 quarters.
Argent Capital Management's Zimmer Biomet position peaked at $48.7M in Q1 2021.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Argent Capital Management's 13F filing for Q1 2022, filed 11 May 2022.